Articles

Expanding coverage for anti-obesity medications without reforming compounding regulation will exacerbate problems with counterfeit drugs. The incoming administration should modernize manufacturing techniques, shore up the supply chain and ban compounding of new obesity medications.

Transparent, simple plan benefits like the proposed model, as well as transparent cost structures throughout the system, have valuable impacts for the beneficiary and the potential to help align incentives throughout the distribution system.

The risk of closure was higher in predominantly Black and Latino neighborhoods, and independent pharmacies were more than twice as likely to face closure.

The overpayment of plans, amounting to $83 billion per year, is unsustainable. The Medicare Advantage payment system needs a broad reform that aligns insurers’ incentives with the needs of beneficiaries and taxpayers.

Over half of Medicare beneficiaries in stand-alone Part D plans kept their coverage without comparing plans during the last enrollment period, and many reported not knowing how to switch plans.

Rosalie Liccardo Pacula, a leading expert on cannabis policy, discusses the public health and social equity impacts of rapidly changing marijuana laws on the PricePod.

Expected monthly out-of-pocket costs for a typical enrollee were about 18-24% lower in Medicare Advantage in recent years, which likely helped fuel the program’s enrollment surge.

Use of newer anti-obesity medications in any part of town can provide true benefit even if lifestyle changes are harder to implement.

USC Price School professor – working with two students – identifies ways to improve cybersecurity of the U.S. healthcare system Earlier this year, a little-known but critical component of the U.S. healthcare system ground to a halt after suffering a cyberattack by a shadowy, transnational organized crime organization called ALPHV/Blackcat. The attack on Change Healthcare, which […]

The annual honors for early-career researchers recognized Erin L. Duffy as a leading expert on key healthcare affordability issues.